Glenmark Pharmaceuticals - News
NSE: GLENMARK | BSE: 532296
₹2,686.00
As on 09-Nov-2026 13:34IST
Market cap
₹75,719 Cr
Revenue (TTM)
₹15,937 Cr
P/E Ratio
52.2
P/B Ratio
6.8
Div. Yield
0.1 %
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsResults-Financial Results For September 30 2026
05-Nov-2026No News & Announcements are available.